Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.
- Published In:
- Stem cell reports, 20(9), 102601 (2025)
- Authors:
- Zeng, Peng-Ming, Sun, Xin-Yao, Li, Yang(3), Wu, Wen-di, Huang, Jing, Cao, Dong-Dong, Qian, Pin-Jue, Ju, Xiang-Chun, Luo, Zhen-Ge
- Database ID:
- RPEP-14467
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14467APA
Zeng, Peng-Ming; Sun, Xin-Yao; Li, Yang; Wu, Wen-di; Huang, Jing; Cao, Dong-Dong; Qian, Pin-Jue; Ju, Xiang-Chun; Luo, Zhen-Ge. (2025). Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.. Stem cell reports, 20(9), 102601. https://doi.org/10.1016/j.stemcr.2025.102601
MLA
Zeng, Peng-Ming, et al. "Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.." Stem cell reports, 2025. https://doi.org/10.1016/j.stemcr.2025.102601
RethinkPeptides
RethinkPeptides Research Database. "Thymosin beta 4 as an Alzheimer disease intervention target ..." RPEP-14467. Retrieved from https://rethinkpeptides.com/research/zeng-2025-thymosin-beta-4-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.